Empagliflozin in combination therapy for treating type 2 diabetes

NICE technology appraisal guidance [TA336] Published date:

What has NICE said?

If a person needs to take 2 antidiabetic drugs, empagliflozin (also known as Jardiance) is recommended as a treatment for type 2 diabetes when taken with a drug called metformin, only if the person:

  • cannot take a type of drug called a sulfonylurea or
  • is at significant risk of hypoglycaemia or its consequences.

If a person needs to take 3 antidiabetic drugs, empagliflozin is recommended as a treatment for type 2 diabetes when taken with either metformin and a sulfonylurea, or with metformin and a type of drug called a thiazolidinedione.

Empagliflozin is also recommended as a treatment for type 2 diabetes when taken with insulin, with or without other antidiabetic drugs.

What does this mean for me?

If you have type 2 diabetes and your doctor thinks that empagliflozin, as described above, is the right treatment, you should be able to have the treatment on the NHS.

Empagliflozin should be available on the NHS within 3 months of the guidance being issued.

If you are not eligible for treatment as described above, you should be able to continue taking empagliflozin until you and your doctor decide it is the right time to stop

Get involved